Proteomic Profiling of Messenger Ribonucleoproteins in Mouse Tissues Based on Formaldehyde Cross-Linking

Jiankun Wang1, Jialin Liu1, Rongbing Huang1

  • 1College of Chemistry and Molecular Engineering, Beijing National Laboratory for Molecular Sciences, Peking-Tsinghua Center for Life Sciences, Synthetic and Functional Biomolecules Center, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking University, Beijing 100871, China.

PubMed

Insights

Messenger ribonucleoprotein particles (mRNPs) are crucial for gene expression. A new method, FAXRAP, allows scientists to identify mRNA-associated proteins (mRAPs) in tissues, revealing insights into diseases like Parkinson's.

Area of Science:

  • Molecular Biology
  • Proteomics
  • Gene Expression Regulation

Background:

  • Messenger ribonucleoprotein particles (mRNPs) regulate tissue-specific gene expression through posttranscriptional mechanisms.
  • Identifying mRNA-associated proteins (mRAPs) within mRNPs at the tissue level presents significant proteomic challenges.

Purpose of the Study:

  • To develop a novel chemical strategy for profiling mRAPs in intact tissues.
  • To systematically identify tissue-specific mRAPs in various mouse organs.
  • To investigate changes in brain mRAPs in a Parkinson's disease model.

Main Methods:

  • Development of formaldehyde cross-linking-based mRNA-associated protein profiling (FAXRAP).
  • Application of FAXRAP to cultured cells and intact mouse organs (liver, kidney, heart, brain).
  • Proteomic analysis of mRAPs in wild-type and Parkinson's disease model mice.

Main Results:

  • FAXRAP successfully enabled the identification of mRAPs in diverse mouse organs.
  • Systematic profiling revealed tissue-specific mRAP landscapes.
  • Investigation in a Parkinson's disease model showed a global decrease in mRNP assembly in the brain.

Conclusions:

  • FAXRAP is an effective chemical strategy for identifying tissue-specific mRAPs.
  • The study provides novel insights into mRNP alterations in Parkinson's disease.
  • FAXRAP is expected to advance the understanding of posttranscriptional regulatory networks.